Tiamulin Market Progresses for Huge Profits by 2026

Tiamulin
is a pleuromutilin antibiotic drug, which is derived
semi-synthetically from natural compound— pleuromutilin—originally
produced by the mushroom–clitopilus scyphoides. Tiamulin is
primarily used as veterinary medicine for treatment of pneumonia,
prophylaxis of dysentery, and mycoplasmal infections in pigs and
poultry. It acts by inhibiting protein synthesis at ribosomal level
and is present in powder and injectable formulations. Antibiotic
properties of Tiamulin aid in treatment of wide range of diseases
caused by bacteria.
Get Exclusive
Sample Report at:
https://www.coherentmarketinsights.com/insight/request-sample/2036
Tiamulin Market:
Drivers
Tiamulin aids in
treatment and prophylaxis of several diseases such as dysentery,
pneumonia, and mycoplasmal infections in pigs and poultry. Increasing
demand for pork and poultry meat along with increase in pig farming
and poultry is expected to propel demand for antibiotic drug tiamulin
and fuel global tiamulin market growth. This is owing to the
susceptibility of pigs and poultry animals to various types of
infections and diseases. According to a report by National Pork
Board, China was the largest pork-producing country in the world.
The country produced around 52,990 thousand metric tons of pork in
2016, which was increased to 53,400 thousand metric tons in 2017.
According to a
report by Federal Statistical Office in 2014, the U.S. was the
largest producer of poultry meat with around 18% of the total meat
produced worldwide. High production of poultry meat is expected to
increase demand for Tiamulin antibiotic drug to treat poultry animals
from various infections. This in turn is expected to propel growth of
the Tiamulin market in the region over the forecast period.
Furthermore,
initiatives by various private and government organizations for
spreading awareness for use of antibiotics in pig farms is expected
to propel global tiamulin market growth over forecast period. For
instance, in 2017, National Pork Board celebrated The U.S. Antibiotic
Awareness Week and World Antibiotic Awareness Week with organizations
such as the U.S. Centers for Disease Control and Prevention (CDC) for
spreading awareness for use of antibiotic drugs in pigs.
Tiamulin Market:
Regional Analysis
North America is
expected to hold a dominant position in the global Tiamulin market
over the forecast period, owing to the presence of key players in the
region along with several strategic mergers and acquisitions amongst
the key players. For instance, in 2015, US-based Eli Lilly and
Company acquired Novartis Animal Health Inc. and its product
–Denagard (tiamulin hydrogen fumarate) and strengthen the position
of Eli Lilly and Company’s animal health business arm Elanco US,
Inc.
Asia Pacific
tiamulin market is expected to witness significant growth over
forecast period, owing to increase in the number of pig farms in the
region. For instance, according to report by Federal Statistical
Office in 2014, China was the largest producer of pork with around
48% of the total pork produced worldwide. Such increasing production
of pork is expected to propel the demand for antibiotics such as
Tiamulin for the treatment of pigs.
Furthermore, Europe
tiamulin market is expected to witness significant growth over the
forecast period, owing to high rates of pork production, which is
expected to increase demand for antibiotic drugs, such as Tiamulin.
For instance, according to a report by National Pork Board, Europe is
the second largest producer of pork worldwide with around 23,866
thousand metric tons pork produced in 2016 and 23,675 thousand metric
tons pork produced in 2017.
Request For
Customization of Research Report @
https://www.coherentmarketinsights.com/insight/request-customization/2036
Tiamulin Market:
Restraint
Use of Tiamulin
results in some side effects, which is expected to be a major factor
hindering growth of the Tiamulin market over the forecast period.
Tiamulin injection can cause pain in the animals and long-term
treatment with Tiamulin results in its resistance in bacteria.
Furthermore,
stringent regulation by U.S. Food and Drug Administration for sale of
Tiamulin drugs is also expected to adversely affect the tiamulin
market growth. For instance, in 2013, U.S. Food and Drug
Administration drafted new guidelines to ban the sale of any
medically use antibiotics for non-medical applications. In 2014,
Novartis Animal Health Inc. (now a part of Eli Lilly and Company)
received warning form FDA, as it promoted its swine antibiotic
product— Denagard (tiamulin hydrogen fumarate) for growth-promotion
aspects.
Tiamulin Market:
Key Players
Key players
operating in the global Tiamulin market include Elanco Inc.,
Hester Biosciences Limited, Huvepharma AD, Jiangsu SEL Biochem,
Shandong Shengli Co Ltd, and others.
Tiamulin Market:
Taxonomy
The global Tiamulin
Market is segmented on the basis of dosage from, target animal,
distribution channel, and region
By Dosage From
Powder
Injectable
By Target Animal
Pigs
Poultry
Others
By Distribution
Channel
Veterinary
Hospital
Retail
Pharmacies
Online
Pharmacies
By Region
North America
Latin America
Europe
Asia Pacific
Middle East
Africa
About Coherent
Market Insights
Coherent Market
Insights is a prominent market research and consulting firm offering
action-ready syndicated research reports, custom market analysis,
consulting services, and competitive analysis through various
recommendations related to emerging market trends, technologies, and
potential absolute dollar opportunity.
Contact Us
Mr. Shah
Coherent Market
Insights
1001 4th Ave, #3200
Seattle, WA 98154
Tel: +1-206-701-6702
Comments
Post a Comment